Cxcr4 antagonists for the treatment of medical disorders

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/28 (2006.01) A61K 31/506 (2006.01)

Patent

CA 2593578

The invention provides compounds, pharmaceutical compositions and methods of use of certain compounds that are antagonists of the chemokine CXCR4 receptor for the treatment of proliferative conditions mediated by CXCR4 receptors. The compounds provided interfere with the binding of SDFl to the receptor. These compounds are particularly, useful for treating or reducing the severity of hyperproliferative diseases by inhibiting metastasis.

L'invention concerne des composés, des compositions pharmaceutiques et des procédés d'utilisation de certains composés qui sont des antagonistes du récepteur de chémokine CXCR4 destinés au traitement d'états prolifératifs médiés par les récepteurs CXCR4. Les composés de l'invention entravent la liaison du SDF1 avec le récepteur. Les composés précités sont particulièrement utiles pour traiter ou réduire la sévérité des maladies hyperprolifératives en inhibant les métastases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cxcr4 antagonists for the treatment of medical disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cxcr4 antagonists for the treatment of medical disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cxcr4 antagonists for the treatment of medical disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1355265

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.